文献速递间质性肺疾病

血小板反应蛋白-1在实验性和人类支气管肺发育不良中起主要致病作用

Thrombospondin-1 Plays a Major Pathogenic Role in Experimental and Human Bronchopulmonary Dysplasia.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究在大鼠新生期予以博来霉素诱导肺损伤,并用LSKL抑制TSP-1介导的TGF-β1活化、用ABT-510模拟TSP-1作用,同时检测47例早产儿尸检肺组织。结果显示TSP-1通过上调TGF-β1活性抑制肺泡发育,人肺标本中TSP-1和TGF-β1升高且TGF-β1与损伤标志物相关。

要点

  • TSP-1通过上调TGF-β1活性抑制新生大鼠肺泡发育。
  • LSKL部分预防博来霉素所致异常肺形态。
  • BPD风险早产儿肺内TSP-1和TGF-β1含量增高。

核心结论

  • TSP-1通过部分上调TGF-β1活性抑制新生大鼠肺泡发育,人肺观察提示TSP-1在BPD风险早产儿中起相似致病作用。

研究设计与样本

  • 新生大鼠生后第1至14天每日腹腔注射博来霉素1 mg/kg或溶媒,并每日皮下注射LSKL 20 mg/kg或溶媒。
  • 另设动物接受溶媒或ABT-510 30 mg/kg/d处理。
  • 对47例胎龄小于29周完成周早产儿尸检石蜡肺组织进行半定量分析,其中对照组(死亡<28天)n=30,BPD风险组(死亡≥28天)n=17。

主要发现

  • 博来霉素或ABT-510增加肺TGF-β1活性及巨噬细胞浸润,引起肺动脉高压和肺泡及微血管发育不良。
  • LSKL治疗部分预防博来霉素所致的异常肺形态。
  • BPD风险早产儿肺内TSP-1和TGF-β1含量较对照组增加。
  • TGF-β1含量与肺损伤标志物相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Extremely preterm infants develop bronchopulmonary dysplasia (BPD), a chronic lung injury that lacks effective treatment. TSP-1 (thrombospondin-1) is an antiangiogenic protein that activates TGF-β1 (transforming growth factor-β1), a cytokine strongly linked to both experimental and human BPD. Objectives:1) To examine effects of inhibiting TSP-1-mediated TGF-β1 activation (LSKL [leucine-serine-lysine-leucine]) in neonatal rats with bleomycin-induced lung injury; 2) to examine effects of a TSP-1 mimic (ABT-510) on lung morphology; and 3) to determine whether TSP-1 and related signaling peptides are increased in lungs of human preterm infants at risk for BPD. Methods: From Postnatal Days 1 to 14, rat pups received daily intraperitoneal bleomycin (1 mg/kg) or vehicle and were treated with daily subcutaneous LSKL (20 mg/kg) or vehicle alone. Separate animals were treated with vehicle or ABT-510 (30 mg/kg/d). Paraffin-embedded lung tissues from 47 autopsies (controls; death <28 d, n = 30 and BPD at risk; death ⩾28 d, n = 17) performed on infants born <29 completed weeks' gestation were semiquantified for injury markers (collagen, macrophages, and 3-nitrotyrosine), TSP-1, and TGF-β1. Measurements and Main Results: Bleomycin or ABT-510 increased lung TGF-β1 activity and macrophage influx, caused pulmonary hypertension, and led to alveolar and microvascular hypoplasia. Treatment with LSKL partially prevented abnormal lung morphology secondary to bleomycin. Lungs from human infants at risk for BPD had increased contents of TSP-1 and TGF-β1 when compared with controls. TGF-β1 content correlated with markers of lung injury. Conclusions: TSP-1 inhibits alveologenesis in neonatal rats, in part via the upregulated activity of TGF-β1. Observations in human lungs suggest a similar pathogenic role for TSP-1 in infants at risk for BPD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ruschkowski BA, Esmaeil Y, Daniel K, et al. Thrombospondin-1 Plays a Major Pathogenic Role in Experimental and Human Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2022. PMID: 35021035. doi:10.1164/rccm.202104-1021OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。